[3] A Stanford faculty member since 2005, he is renowned for his expertise in gynecologic oncology, surgical innovation and technique, and research in ovarian cancer, especially immunology and immunotherapy.
His past laboratory research focused on fundamental mechanisms of cancer immunology, elucidating growth regulatory pathways for cytokines and their receptors.
His current research focuses on clinical trials of novel therapies and immunotherapies for ovarian cancer and collaborations on new diagnostics, screening techniques, and genetics.
[2] An author and editor, Dr. Berek has published more than 330 peer-reviewed manuscripts in the scientific literature, and an equal number of book chapters and monographs.
[9] In 2003, Dr. Berek received the highly prestigious Sherman Mellinkoff Award from the David Geffen School of Medicine at UCLA.